Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?

SJ Kent, DS Khoury, A Reynaldi, JA Juno… - Nature Reviews …, 2022 - nature.com
The rapid development of multiple vaccines providing strong protection from severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been a major achievement …

The immune response to SARS-CoV-2 in people with HIV

MA Höft, WA Burgers, C Riou - Cellular & Molecular Immunology, 2024 - nature.com
This review examines the intersection of the HIV and SARS-CoV-2 pandemics. People with
HIV (PWH) are a heterogeneous group that differ in their degree of immune suppression …

Immunogenicity and efficacy of vaccine boosters against SARS-CoV-2 Omicron subvariant BA. 5 in male Syrian hamsters

RRG Machado, JL Walker, D Scharton… - Nature …, 2023 - nature.com
Abstract The SARS-CoV-2 Omicron subvariant BA. 5 rapidly spread worldwide and replaced
BA. 1/BA. 2 in many countries, becoming globally dominant. BA. 5 has unique amino acid …

Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study

LC Netto, KY Ibrahim, CM Picone, APPS Alves… - The Lancet …, 2022 - thelancet.com
Background People living with HIV might have a poor or delayed response to vaccines,
mainly when CD4 cell counts are low, and data concerning COVID-19 vaccines in this …

[HTML][HTML] Immunogenicity and efficacy of COVID-19 vaccines in people living with HIV: a systematic review and meta-analysis

J Yin, Y Chen, Y Li, C Wang, X Zhang - International Journal of Infectious …, 2022 - Elsevier
Objectives Available data show that COVID-19 vaccines may be less effective in people
living with HIV (PLWH) who are at increased risk for severe COVID-19. This meta-analysis …

Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV

L Ao, T Lu, Y Cao, Z Chen, Y Wang, Z Li… - Emerging microbes & …, 2022 - Taylor & Francis
It is important to know the safety and efficacy of vaccination in immunocompromised people
living with HIV (PLWH), but currently, there is limited data on the inactivated SARS-CoV-2 …

Immunologic interplay between HIV/AIDS and COVID-19: adding fuel to the flames?

M Augello, V Bono, R Rovito, C Tincati… - Current HIV/AIDS …, 2023 - Springer
Abstract Purpose of Review HIV/AIDS and COVID-19 have been the major pandemics
overwhelming our times. Given the enduring immune disfunction featuring people living with …

[HTML][HTML] People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose …

HR Lapointe, F Mwimanzi, PK Cheung, Y Sang… - medRxiv, 2022 - ncbi.nlm.nih.gov
Background: Longer-term humoral responses to two-dose COVID-19 vaccines remain
incompletely characterized in people living with HIV (PLWH), as do initial responses to a …

SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8+ T-cells

EM Stevenson, S Terry, D Copertino, L Leyre… - Nature …, 2022 - nature.com
Efforts to cure HIV have focused on reactivating latent proviruses to enable elimination by
CD8+ cytotoxic T-cells. Clinical studies of latency reversing agents (LRA) in antiretroviral …

The effect of HIV on COVID-19 vaccine responses

I Levy, G Rahav - Current Opinion in HIV and AIDS, 2023 - journals.lww.com
The effect of HIV on COVID-19 vaccine responses : Current Opinion in HIV and AIDS The effect
of HIV on COVID-19 vaccine responses : Current Opinion in HIV and AIDS Log in or Register …